title: Hepatocellular carcinoma: diagnosis, management, and prognosis.
abstract: The successful management of hepatocellular carcinoma (HCC) requires a multidisciplinary approach, incorporating hepatologists, oncologists, surgical oncologists, transplant surgeons, and radiologists. With improvements in technology and better long-term outcomes data, management strategies for HCC have become more methodical and more successful. This article focuses on some of the most critical advances relating to carcinogenesis, surveillance, and management.
authors.affiliation: Department of Surgery, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Page
authors.affiliation: Department of Medical Oncology, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA.
authors.forename: David C
authors.initials: DC
authors.lastname: Cosgrove
authors.affiliation: Department of Surgery, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Philosophe
authors.affiliation: Division of Surgical Oncology, Department of Surgery, Johns Hopkins Hospital, 600 North Wolfe Street, Blalock 688, Baltimore, MD 21287, USA. Electronic address: tpawlik1@jhmi.edu.
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Pawlik
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000628:therapy; D011379:Prognosis
keywords: Hepatocellular carcinoma; Locoregional therapy; Sorafenib; Transarterial chemoembolization (TACE); Transplantation